Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.

Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.

Item
http://www.wikidata.org/entity/Q50859753
Role of Neuropilin-1 in Diabetic NephropathyErythropoietin action in stress response, tissue maintenance and metabolism.A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice.Restoration of Haemoglobin Level Using Hydrodynamic Gene Therapy with Erythropoietin Does Not Alleviate the Disease Progression in an Anaemic Mouse Model for TGFβ1-Induced Chronic Kidney Disease.A Possible Mechanism for Renoprotective Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Elevation of Erythropoietin Production.The role of hypoxia and Morg1 in renal injury.Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis.Targeting erythropoietin protects against proteinuria in type 2 diabetic patients and in zebrafish.Heterozygosity of mitogen-activated protein kinase organizer 1 ameliorates diabetic nephropathy and suppresses epithelial-to-mesenchymal transition-like changes in db/db mice.CERA Attenuates Kidney Fibrogenesis in the db/db Mouse by Influencing the Renal Myofibroblast Generation.Long-term expression of glomerular genes in diabetic nephropathy.Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial.Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21.Noninvasive Real-Time Characterization of Renal Clearance Kinetics in Diabetic Mice after Receiving Danshensu Treatment.SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.
P2860

Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.

Item
http://www.wikidata.org/entity/Q50859753
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Erythropoietin ameliorates pod ...... ephropathy in the db/db mouse.
@en
Erythropoietin ameliorates pod ...... ephropathy in the db/db mouse.
@nl
type
label
Erythropoietin ameliorates pod ...... ephropathy in the db/db mouse.
@en
Erythropoietin ameliorates pod ...... ephropathy in the db/db mouse.
@nl
prefLabel
Erythropoietin ameliorates pod ...... ephropathy in the db/db mouse.
@en
Erythropoietin ameliorates pod ...... ephropathy in the db/db mouse.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Erythropoietin ameliorates pod ...... ephropathy in the db/db mouse.
@en
P2093
P2860
P304
P31
P356
10.1152/AJPRENAL.00643.2012
P433
P478
P577
P698
P921